Abstract
The psychotropic actions of opiates and opioid peptides are mediated by interaction with µ, δ, and κ opioid receptors and the related σ receptor. The µ receptor is operationally defined as the high-affinity site at which morphine-like opioids produce analgesia and other classical opioid effects. The δ receptor is operationally defined as the receptor that is found in peripheral tissues such as the mouse vas deferens (Lord et al., 1977) as well as in the CNS (Chang et al., 1979), and that exhibits a higher affinity for the naturally occurring enkephalins (shorter opioid peptides) than for morphine. The κ receptor is the receptor at which ketocyclazocine-like opioids produce analgesia as well as their unique ataxic and sedative effects (Gilbert and Martin, 1976; Martin et al., 1976). More recently it has been defined as a receptor highly selective for dynorphin, a 17-amino acid opioid peptide (Chavkin et al., 1982). Actions at all three of these sites are reversible by the specific opioid antagonist naloxone, with decreasing sensitivity going from µ to δ to κ receptors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anis, N. A., Berry, S. C., Burton, N. R. and Lodge, D. (1983) The dissociative anaesthetics ketamine and phencyclidine selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br. J. Pharmacol. 79, 565–575.
Atweh, S. F. and Kuhar, M. J. (1977) Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon. Brain Res. 134, 393–405.
Berry, S. C., Dawkins, S. L., and Lodge, D. (1984) A comparison of sigma and kappa opiate receptor ligands as excitatory amino acid antagonists. Br. J. Pharmacol. 83, 179–185.
Brady, K. T. and Balster, R. L. (1982) Discriminative stimulus properties of stereoisomers of cyclazocine in phencyclidine-trained squirrel monkeys. Life Sci. 31, 541–549.
Brady, K. T., Balster, R. L., and May, E. L. (1982) Stereoisomers of N-allylnormetazocine: Phencyclidine-like behavioral effects in squirrel monkeys and rats. Science 215, 178–180.
Browne, R. G. and Welch, W. M. (1982) Stereoselective antagonism of phencyclidine’s discriminative properties by adenosine receptor agonists. Science 217, 1157–1159.
Chang, K.-J. Cooper, B. R., Hazum, E., and Cuatrecasas, P. (1979) Multiple opiate receptors: Different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol. Pharmacol. 16, 91–104.
Chavkin, C., James, I. F., and Goldstein, A. (1982) Dynorphin is a specific endogenous ligand of the K opioid receptor. Science 215, 413–415.
Davies, B. M. and Beech, H. R. (1960) The effects of 1-arylcyclohexylamine (Sernyl) on twelve normal volunteers. J. Ment. Sci. 106, 912–924.
Eghbali, M., Tempel, A., Henriksen, S., and Zukin, R. S. (1987) Characterization and visualization of brain kappa opiate receptors: Evidence for a conformational change, submitted for publication.
Gilbert, P. E. and Martin, W. R. (1976) The effects of morphine and morphine-like drugs in the nondependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 198, 66–82.
Goldstein, A., Tachibana, S., Lowney, L. I., Hunkapiller, M., and Hood, L. (1979) Dynorphin-(1–13): An extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. USA 76, 6666–6670.
Goodman, R. R., Snyder, S. H., Kuhar, M. J., and Young, W. S., III (1980) Differentiation of delta and mu receptor localizations by light microscopic autoradiography. Proc. Natl. Acad. Sci. USA 77, 6239–6243.
Greenberg, B. D. and Segal, D. S. (1985) Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: Evidence for a dopaminergic role in some PCP-induced behaviors. Pharmacol. Biochem. Behay. 23, 99–105.
Guillemin, R., Ling, N., and Burgus, R. (1976) Endorphins, peptides d’origine hypothalamique et neurohypophysaire d’activite morphinomimetique. Isolement et structure moleculaire d’alpha-endorphine, C.R. Hebd. Seances Acad. Sci. ser. D 282, 783–785.
Gundlach, A. L., Largent, B. L., and Snyder, S. H. (1985) Phencyclidine and sigma opiate receptors in brain: Biochemical and autoradiographical differentiation. Eur. J. Pharmacol. 113, 465–466.
Gundlach, A. L., Largent, B. L., and Snyder, S. H. (1986) Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-Hydroxyphenyl)-N-(1-propyl)piperidine J. Neurosci. 6, 1757–1770.
Haertzen, C. A. (1970) Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI). Psychopharmacologia 18, 366–367.
Haertzen, C. A. (1974) Advances in Biochemical Psychopharmacology, in Subjective Effects of Narcotic Antagonists vol. 8 (Brande, M., Harris, L., May, E., Smith, J. P., and Villereal, J., eds.) Raven, New York.
Hampton, R. Y., Medzihradsky, F., Woods, J. H., and Dahlstrom, P. J. (1982) Stereospecific binding of [3H]-phencyclidine in brain membranes. Life Sci. 30, 2147–2154.
Haring, R., Kloog, Y., and Sokolovsky, M. (1986) Identification of polypeptides of the phencyclidine (PCP) receptor of rat hippocampus by photo-affinity labeling with [3H]azidophencyclidine. Biochemistry 25, 612–620.
Herkenham, M. and Pert, C. B. (1980) In vitro autoradiography of opiate receptors in rat brain suggest loci of “opiatergic” pathways. Proc. Natl. Acad. Sci. USA 77, 5532–5536.
Herling, S. and Woods, J. H. (1981) Discriminative stimulus effects of narcotics: Evidence for multiple receptor mediated actions. Life Sci. 28, 1571–1584.
Holtzman, S. G. (1974) Narcotic Antagonists as Stimulants of Behavior in the Rat: Specific and Nonspecific Effects, in Advances in Biochemical Psychopharmacology vol. 8: Narcotic Antagonists ( Braude, M. C., Harris, L. S., May, E. L., Smith, J. P., and Villarreal, J. E., eds.) Raven, New York.
Holtzman, S. G. (1980) Phencyclidine-like discriminative effects of opioids in the rat. J. Pharmacol. Exp. Ther. 214, 614–619.
Holtzman, S. G. (1982) Phencyclidine-like discriminative stimulus proper- ties of psychotomimetic opioids. Ann. NY Acad. Sci. 398, 230–240.
Hughes, J. (1985) Opioid Peptides-Families of Receptors and Neurotransmitters, in Neurotransmitters in Action ( Bousefield, D., ed.) Elsevier, New York.
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., and Morris, H. R. (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258, 577–579.
Itzhak, Y., Hiller, J. M., and Simon, E. J. (1985) Characterization of specific binding sites for [3H] (d)-N-allylnormetazocine in rat brain membranes. Mol. Pharmacol. 27, 46–52.
James, I., Chavkin, C., and Goldstein, A. (1982) Selectivity of dynorphin for K opioid receptors. Life Sci. 31, 1331–1334.
Javitt, D. C., Jotkowitz, A., Sircar, R., and Zukin, S. R. (1987) Noncompetitive regulation of PCP receptors by the NMDA receptor antagonist D(-)AP5. Neurosci. Lett.,in press.
Johnstone, M., Evans, V., and Baigel, S. (1959) Sernyl (CI-395) in clinical anesthesia. Br. J. Anaesth. 31, 433–439.
Kuhar, M. J. (1982) Localization of Drug and Neurotransmitter Receptors in Brain by Light Microscopic Autoradiography, in Handbook of Psychopharmacology vol. 15 (Iverson, L. L., Iverson, S. D., and Snyder, S. H., eds.) Plenum, New York.
Lacey, M. G. and Henderson, G. (1986) Actions of phencyclidine on rat locus coeruleus neurones in vitro. Neuroscience 2, 485–494.
Largent, B. L., Gundlach, A. L., and Snyder, S. H. (1984) Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]-(3-hydroxyphenyl)-N-(1-propyl)piperidphe Proc. Natl. Acad. Sci. USA 81, 4983–4987.
Largent, B. L., Gundlach, A. L, and Snyder, S. H. (1986) Pharmacological and autoradiographic discrimination of sigma and phencyclidine recep-tor binding sites in brain with (+)-[3H] SKF 10,047, (+)-[3H]-3-[3hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 238, 739–748.
Lasagna, L., Dekornfeld, T. J., and Pearson, J. W. (1964) The analgesic efficacy and respiratory effects in man of a benzomorphan “narcotic antagonist.” J. Pharmacol. Exp. Ther. 144, 12–16.
Li, C. H. and Chung, D. (1976) Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc. Natl. Acad. Sci. USA 73, 1145–1148.
Lodge, D., Anis, N. A., Berry, S. C., and Burton, N. R. (1983) Arylcyclohexamines Selectively Reduce Excitation of Mammalian Neurones by Aspartate-Like Amino Acids, in Phencyclidine and Related Arylcyclohexamines: Present and Future Applications ( Kamenka, J.-M., Domino, E. F., and Geneste, P., eds.) NPP, Ann Arbor, Michigan.
Lodge, D., Berry, S. C., Church, J., Martin, D., McGhee, A., Lai, H. M., and Thomson, A. M. (1984) Isomers of cyclazocine as excitatory amino acid antagonists. Neuropeptides 5, 245–248.
Loo, P., Braunwalder, A., Lenmann, J., and Williams, M. (1986) Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor antagonists. Eur. J. Pharmacol. 123, 467–468.
Lord, J. A. H., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W. (1977) Endogenous opioid peptides: Multiple agonists and receptors. Nature (Lond.) 267, 495–500.
Luby, E. D., Cohen, B. D., Rosenbaum, G., Gottlieb, J., and Kelly, R. (1959) Study of a new schizophrenomimetic drug—sernyl. AMA Arch. Neurol. Psychiat. 81, 363–369.
Martin, B. R., and Lodge, D. (1985) Ketamine Acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro. Neuropharmacology 24, 999–1003.
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., and Gilbert, P. E. (1976) The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517–532.
Martin, B. R., Katzen, J. S., Woods, J. A., Tripathi, H. L., Harris, L. S., and May, E. L. (1984) Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain. J. Pharmacol. Exp. Ther. 231, 539–544.
Mendelsohn, L. G., Karchner, G. A., Kalra, V., Zimmerman, D. M., and Leander, J. D. (1984) Phencyclidine receptors in rat brain cortex. Biochem. Pharmacol. 33, 3529–3535.
Munson, P. J. and Rodbard, D. (1980) Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220–226.
Pasternak, G. W., Carroll-Buatti, M., and Spiegel, K. (1981) The binding and analgesic properties of a sigma opiate, SKF-10,047. J. Pharmacol. Exp. Ther. 219, 192–198.
Quirion, R., Jr., Hammer, R. P., Herkenham, M., and Pert, C. B. (1981) A phencyclidine/sigma opiate receptor: Its visualization by tritium-sensitive film. Proc. Natl. Acad. Sci. USA 78, 5881–5885.
Quirion, R., DiMaggio, D. A., French, E. D., Contreras, P. C., Shiloch, J., Pert, C. B., Everist, H., Pert, A., and O’Donohue, T. L. (1984) Evidence for an endogenous peptide ligand for the phencyclidine receptor. Peptides 5, 967–973.
Shannon, H. E. (1982) Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats. J. Pharmacol. Exp. Ther. 216, 543–551.
Shearman, G. T. and Herz, A. (1982) Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat. Eur. J. Pharmacol. 82, 167–172.
Sircar, R. and Zukin, S. R. (1985) Visualization of [3H]TCP binding in rat brain by quantitative light-microscopy autoradiography. Brain Res. 344, 142–145.
Sircar, R., Nichtenhauser, R., Ieni, J. R., and Zukin, S. R. (1986) Characterization and autoradiographic visualization of [3H](+)SKF-10,047 binding in rat and mouse brain: Further evidence for phencyclidine/“sigma opiate” receptor commonality. J. Pharmacol. Exp. Ther., 237, 681–688.
Slifer, B. L. and Balster, R. L. (1985) Phencyclidine-like discriminative stimulus properties of the stereoisomers of dioxadrol. Subst. Alcohol Actions Misuse 5 (6), 273–280.
Snell, L. D. and Johnson, K. M. (1985) Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J. Pharmacol. Exp. Ther. 235, 50–57.
Snell, L. D. and Johnson, K. M. (1986) Characterization of the inhibition of excitatory amino acid-induced transmitter release in the rat striatum by phencyclidine-like drugs. J. Pharmacol. Exp. Ther. 238, 938–946.
Su, T.-P. (1981) Psychotomimetic opioid binding: Specific binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. Eur. J. Pharmacol. 75, 81–91.
Su, T.-P. (1982) Evidence for sigma opioid receptor: Binding of [3H]SKF 10,047 to etorphine-accessible sites in guinea-pig brain. J. Pharmacol. Exp. Ther. 223, 284–290.
Su, T.-P., Weissman, A. D., and Yeh, S. Y. (1986) Endogenous ligands for sigma opioid receptors in the brain (“sigmaphin”): Evidence from binding assays. Life Sci. 24, 2199–2210.
Tam, S. W. (1983) Naloxone-inaccessible receptor in rat central nervous system. Proc. Natl. Acad. Sci. USA 80, 6703–6707.
Tam, S. W. (1985) (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, µ, K, 8 and phencyclidine bindings sites in guinea pig brain membranes. Eur. J. Pharmacol. 109, 33–41.
Tam, S. W. and Cook, L. (1984) a Opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA 80, 5618–5621.
Teal, J. J. and Holtzman, S. G. (1980a) Discriminative stimulus effects of cyclazocine in the rat. J. Pharmacol. Exp. Ther. 212, 368–376.
Teal, J. J. and Holtzman, S. G. (1980b) Discriminative stimulus effects of prototype opiate receptor agonists in monkeys. Eur. J. Pharmacol. 68, 1–10.
Thompson, A. M. and Lodge, D. (1985) Selective blockade of an excitatory synapse in rat cerebral cortex by the sigma opiate cyclazocine: An intracellular, in vitro study. Neurosci. Lett. 54, 21–26.
Thompson, A. M., West, D. C., and Lodge, D. (1985) An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: A site of action of ketamine? Nature (Lond.) 313, 479–481.
Vaupel, B. (1983) Naloxone fails to antagonize the o-effects of PCP and SKF 10,047 in the dog. Eur. J. Pharmacol. 92, 269–274.
Vaupel, D. B., Risner, M. E., and Shannon, H. E. (1986) Pharmacologic and reinforcing properties of phencyclidine and the enantiomers of N-allylnormetazocine in the dog. Drug Alcohol Depend. 18, 173–194.
Vignon, J., Vincent, J. P., Bidard, J. N., Kamenka, J. M., Geneste, P., Monier, S., and Lazdunski, M. (1982) Biochemical properties of the brain phencyclidine receptor. Eur. J. Pharmacol. 81, 531–543.
Vignon, J., Chicheportiche, R., Chicheportiche, M., Kamenka, J.-M., Geneste, P., and Lazdunski, M. (1983) [3H]TCP: A new tool with high affinity for the PCP receptor in rat brain. Brain Res. 280, 194–197.
Vincent, J. P., Kartalovski, B., Geneste, P., Kamenka, J. M., and Lazdunski, M. (1979) Interaction of phencyclidine (“angel dust”) with a specific receptor in rat brain membranes. Proc. Natl. Acad. Sci. USA 76, 4678–4682.
Vincent, J. P., Vignon, J., Kartalovski, B., and Lazdunski, M. (1980) Compared properties of central and peripheral binding sites for phencyclidine. Eur. J. Pharmacol. 68, 79–82.
Wang, Y., Palmer, M. R., Freedman, R., Rice, K. C., Lessor, R. A., Jacobson, A. E., and Hoffer, B. J. (1986) Electrophysiological interactions of isomers of cyclazocine with the phencyclidine antagonist metaphit in rat cerebellar Purkinje neurons. J. Neurosci. 11, 3189–3196.
Zukin, S. R. (1982) Differing stereospecificites distinguish opiate receptor subtypes. Life Sci. 31, 1307–1310.
Zukin, R. S. and Zukin, S. R. (1981) Demonstration of [3H]-cyclazocine binding to multiple opiate receptor sites. Mol. Pharmacol. 20, 246–254.
Zukin, S. R. and Zukin, R. S. (1979) Specific [3H]-phencyclidine binding in rat central nervous system. Proc. Natl. Acad. Sci. USA 76, 5372–5376.
Zukin, S. R., Fitz-Syage, M. L., Nichtenhauser, R., and Zukin, R. S. (1983) Specific binding of [3H]-phencyclidine in rat central nervous tissue: Further characterization and technical considerations. Brain Res. 258, 277–284.
Zukin, S. R., Brady, K. T., Slifer, B. L., and Balster, R. L. (1984) Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors. Brain Res. 294, 174–177.
Zukin, S. R., Tempel, A., Gardner, E. L., and Zukin, R. S. (1986) Interaction of [3H] (-)-SKF-10,047 with brain o-receptors: Characterization and autoradiographic visualization. J. Neurochem. 46, 1032–1041.
Zukin, S. R., Zukin, R. S., Vale, W., Rivier, J., Nichtenhauser, R., Snell, L. D., and Johnson, K. M. (1987) An endogenous ligand of the brain if/PCP receptor antagonizes NMDA-induced neurotransmitter release. Brain Res.,in press.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zukin, R.S., Zukin, S.R. (1988). The σ Receptor. In: Pasternak, G.W. (eds) The Opiate Receptors. The Receptors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-990-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-60761-990-1_5
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6768-1
Online ISBN: 978-1-60761-990-1
eBook Packages: Springer Book Archive